Academic literature on the topic 'Psychotropic drugs'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Psychotropic drugs.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Psychotropic drugs"
Khrypunova, Tetiana. "Relationships between the Ukrainian Public's Awareness of Psychotropic Drugs, Stigmatizing People Taking Psychotropic Drugs and Stopping Psychotropic Drug Medication without Consulting with a Doctor." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 6, no. 5 (October 27, 2021): 370–75. http://dx.doi.org/10.26693/jmbs06.05.370.
Full textTherrien, Rachel. "Managing Psychotropic Drugs with Efavirenz." Canadian Journal of Infectious Diseases and Medical Microbiology 17, suppl d (2006): 15D—16D. http://dx.doi.org/10.1155/2006/736415.
Full textWancata, J., N. Benda, U. Meise, and C. Müller. "Use of Psychotropic Drugs in Gynecological, Surgical, and Medical Wards of General Hospitals." International Journal of Psychiatry in Medicine 28, no. 3 (September 1998): 303–14. http://dx.doi.org/10.2190/8xtv-38n6-ewbj-08f1.
Full text&NA;. "Psychotropic drugs." Inpharma Weekly &NA;, no. 1197 (July 1999): 19. http://dx.doi.org/10.2165/00128413-199911970-00034.
Full textEngstrom, Frederick, Kathryn (Kay) L. Hong, and Daniel G. Blazer. "Psychotropic drugs." Postgraduate Medicine 101, no. 3 (March 1997): 198–211. http://dx.doi.org/10.3810/pgm.1997.03.174.
Full textMericle, Bruce P. "Psychotropic Drugs." Journal of Psychosocial Nursing and Mental Health Services 35, no. 10 (October 1997): 47. http://dx.doi.org/10.3928/0279-3695-19971001-21.
Full textLoudon, J. B. "Psychotropic drugs." BMJ 294, no. 6565 (January 17, 1987): 167–69. http://dx.doi.org/10.1136/bmj.294.6565.167.
Full textMüller-Spahn. "Psychotropic drugs." Therapeutische Umschau 56, no. 12 (December 1, 1999): 719–25. http://dx.doi.org/10.1024/0040-5930.56.12.719.
Full textPaulina Maya Octasari and Devita Wityaninda. "Pola Peresepan Obat Psikotropika Di Apotek Karangrejo Kota Semarang." Journal Clinical Pharmacy and Pharmaceutical Science 2, no. 2 (November 1, 2023): 09–19. http://dx.doi.org/10.61740/jcp2s.v2i2.39.
Full textMalm, Ulf. "Psychotropic drugs. Treatment of mental disorders with psychotropic drugs." Nordic Journal of Psychiatry 53, no. 4 (January 1999): 319–20. http://dx.doi.org/10.1080/080394899427142.
Full textDissertations / Theses on the topic "Psychotropic drugs"
Antona, Annamaria. "Repurposing of psychotropic drugs for cancer therapy." Doctoral thesis, Università del Piemonte Orientale, 2021. http://hdl.handle.net/11579/127826.
Full textChan, Kin-yi Ivy. "A study of determinants of relapse in psychotropic substance abuse /." Hong Kong : University of Hong Kong, 1995. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19470757.
Full textMitchell, Alexander Lawson. "Regulation of 5-HT receptors by psychotropic drugs." Thesis, University of Oxford, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298235.
Full textGoldwasser, Ruth Pilczyk. "The usage of psychotropic medications by family caregivers /." Connect to thesis, 1996. http://eprints.unimelb.edu.au/archive/00002534.
Full textMoorman, Jennifer Mary. "Studies on neuroadaptation to psychotropic drugs involving serotonergic receptor function." Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.244529.
Full textPurcell, Gregory Mark. "Intervention to improve the level of documentation of antipsychotic related adverse drug reactions." Thesis, Nelson Mandela Metropolitan University, 2014. http://hdl.handle.net/10948/10340.
Full textGolby, Jim. "Psychopharmacological aspects of skilled behaviour." Thesis, University of Leeds, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.329505.
Full textChan, Kin-yi Ivy, and 陳健儀. "A study of determinants of relapse in psychotropic substance abuse." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1995. http://hub.hku.hk/bib/B31250038.
Full textBeckett, Nicola Michelle. "Isotopic Profiling of Selected Designer Drugs for Forensic Intelligence Purposes." Thesis, Griffith University, 2015. http://hdl.handle.net/10072/366425.
Full textThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
Institute for Glycomics
Science, Environment, Engineering and Technology
Full Text
Confer, Jennifer, and Deborah Laird. "Psychotropic Polypharmacy in Outpatients with Schizophrenia: Comparison of Oral Psychotropic Adherence Rates, Duplication of Therapy, Psychiatric Hospitalizations, Cost of Services, and Concomitant Medications." The University of Arizona, 2007. http://hdl.handle.net/10150/624327.
Full textObjectives: A prescription claims database from COPE Behavioral Services in Tucson, Arizona was used to retrospectively assess the differences between patients receiving <4 and those receiving > 4 psychotropic medications over a 12-month period in adult patients with schizophrenia. Methods: Medication groups (i.e., < 4 versus > 4 concomitant psychotropic agents) were compared for differences in gender, age, duplication of antipsychotic therapy, adherence rates, court order treatment status, psychiatric hospitalization rates and length of stay, cost of services provided, and concomitant psychotropic medications. Results: A total of 506 adult patients with schizophrenia (F=214 and M=292) met the inclusion criteria for receiving psychotropic medications during the 12-month study. Of those, 388 patients (76.7%) were found to have an average of < 4 medications, while 118 patients (23.3%) were found to have > 4 medications. Duplication of antipsychotic therapy was more common in the > 4 group (29.7%) compared to the < 4 group (3.1%), p < 0.001. Psychotropic adherence rates were significantly higher in the > 4 group based on month’s supply of prescriptions. Demographic differences between groups included: increased age, more women, fewer court order status, and higher cost of care in the > 4 compared to the < 4 medication group. No differences in hospitalizations, length of stay, and hospital costs were found between groups. Conclusions: Our findings suggest that patients with schizophrenia with increased rates of polypharmacy have higher adherence rates, more duplication of antipsychotics, and a higher cost of care (i.e., case management, laboratory, other services, total prescription costs) compared to patients receiving < 4 psychotropic medications.
Books on the topic "Psychotropic drugs"
G, Folks David, ed. Psychotropic drugs. St. Louis: Mosby, 1993.
Find full textG, Folks David, ed. Psychotropic drugs. 2nd ed. St. Louis: Mosby, 1997.
Find full text1947-, Bezchlibnyk-Butler Kalyna Z., and Jeffries J. Joel 1939-, eds. Clinical handbook of psychotropic drugs. 9th ed. Seattle: Hogrefe & Huber Publishers, 1999.
Find full textK, Balfour D. J., ed. Psychotropic drugs of abuse. Oxford: Brand: Pergamon Pr, 1989.
Find full textCorporation, Springhouse, ed. Handbook of psychotropic drugs. Springhouse, Pa: Springhouse Corporation, 1992.
Find full textK, Balfour D. J., ed. Psychotropic drugs of abuse. New York: Pergamon Press, 1990.
Find full textH, Kennedy Sidney, and McIntyre Roger S, eds. Psychotropic drugs: Fast facts. 4th ed. New York: W.W. Norton & Company, 2008.
Find full textG, Ward Nicholas, and Dubovsky Steven L, eds. Psychotropic drugs: Fast facts. 3rd ed. New York: Norton, 2002.
Find full textG, Ward Nicholas, ed. Psychotropic drugs: Fast facts. 2nd ed. New York: Norton, 1995.
Find full textAndrius, Baskys, and Remington Gary, eds. Brain mechanisms and psychotropic drugs. Boca Raton: CRC Press, 1996.
Find full textBook chapters on the topic "Psychotropic drugs"
Patsalos, P. N. "Psychotropic Drugs." In Antiepileptic Drug Interactions, 361–87. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-2434-4_62.
Full textPatsalos, Philip N. "Psychotropic Drugs." In Antiepileptic Drug Interactions, 285–301. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32909-3_66.
Full textBaker, Julien S., Fergal Grace, Lon Kilgore, David J. Smith, Stephen R. Norris, Andrew W. Gardner, Robert Ringseis, et al. "Psychotropic Drugs." In Encyclopedia of Exercise Medicine in Health and Disease, 736. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_2930.
Full textPatsalos, Philip N. "Psychotropic Drugs." In Antiseizure Medication Interactions, 319–35. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-82790-8_73.
Full textIaboni, Andrea, and Benoit H. Mulsant. "Psychotropic Drugs." In Medication-Related Falls in Older People, 105–24. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32304-6_9.
Full textGianturco, Daniel Thomas. "Psychotropic Drugs." In Principles of Medical Therapy in Pregnancy, 906–11. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2415-7_136.
Full textMasson, Sylvia, Stéphane Bleuer-Elsner, Gérard Muller, Tiphaine Médam, Jasmine Chevallier, and Emmanuel Gaultier. "Miscellaneous Psychotropic Drugs." In Veterinary Psychiatry of the Dog, 753–78. Cham: Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-031-53012-8_26.
Full textLittle, “Bert” Bertis Britt. "Psychotropic Use during Pregnancy." In Drugs and Pregnancy, 208–30. 2nd ed. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9780429160929-10.
Full textKerns, Lawrence L., and Gilla P. Davis. "Psychotropic Drugs in Pregnancy." In Drug Use in Pregnancy: Mother and Child, 81–93. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4157-1_9.
Full textBircher, Andreas J., and Knut Brockow. "Antiepileptic and Psychotropic Drugs." In Cutaneous Drug Hypersensitivity, 257–66. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-82743-4_29.
Full textConference papers on the topic "Psychotropic drugs"
Amann, F. J., K. Endres, C. Hiemke, G. Zernig, G. Gründer, and X. M. Hart. "Update on dose-related reference ranges for psychotropic drugs." In XVth Symposium of the Task Force Therapeutic Drug Monitoring of the AGNP. Georg Thieme Verlag, 2024. http://dx.doi.org/10.1055/s-0044-1779583.
Full textHart, XM, G. Gründer, and C. Hiemke. "10 How valid are therapeutic reference ranges for psychotropic drugs?" In XIVth Symposium of the Task Force Therapeutic Drug Monitoring of the AGNP. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1710118.
Full textGorbatova, Marina A. "Some Questions Concerning the Theft of Narcotic Drugs or Psychotropic Substances." In АКТУАЛЬНЫЕ ВОПРОСЫ РАЗВИТИЯ ГОСУДАРСТВЕННОСТИ И ПУБЛИЧНОГО ПРАВА. Санкт-Петербург: Санкт-Петербургский институт (филиал) ВГУЮ (РПА Минюста России), 2022. http://dx.doi.org/10.47645/9785604755174_48.
Full textRaharni, Sri Idaiani, Isfandari, and Irmansyah. "Relapse in Drugs, Psychotropic, Addictive Abuse Post Rehabilitation: “Policy and Prevention Programs”." In 4th International Symposium on Health Research (ISHR 2019). Paris, France: Atlantis Press, 2020. http://dx.doi.org/10.2991/ahsr.k.200215.011.
Full text"PUBLIC DANGER OF CRIMES RELATED TO ILLICIT TRAFFICKING OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES." In Russian science: actual researches and developments. Samara State University of Economics, 2020. http://dx.doi.org/10.46554/russian.science-2020.03-2-437/439.
Full textSimonovski, Ivica, and Biljana Bogdanova – Smilevska. "LEGALIZATION OF CANNABIS PRODUCTION FOR MEDICAL PURPOSES IN MACEDONIA - IMPLICATION FOR LEGAL AMENDMENTS (POSITIVE VS NEGATIVE EFFECTS)." In SECURITY HORIZONS. Faculty of Security- Skopje, 2021. http://dx.doi.org/10.20544/icp.2.4.21.p17.
Full textРоман Анатольевич, Калёкин,, Волкова, Алла Андреевна, Павлова, Альбина Захаровна, Орлова, Алевтина Михайловна, and Павлов, Андрей Леонидович. "TOXIC EFFECTS OF BENZODIAZEPINE RECEPTOR AGONISTS." In Теоретические основы и практическое применение инновационных исследований: сборник статей международной научной конференции (Москва, Ноябрь 2022). Crossref, 2022. http://dx.doi.org/10.37539/221111.2022.42.92.006.
Full textАлла Андреевна, Волкова,, Калёкин, Роман Анатольевич, Орлова, Алевтина Михайловна, Павлова, Альбина Захаровна, and Павлов, Андрей Леонидович. "HIGH-TECH TECHNIQUES FOR DETECTING BENZODIAZEPINE RECEPTOR AGONISTS IN POISONING." In Высокие технологии и инновации в науке: сборник статей международной научной конференции (Санкт-Петербург, Ноябрь 2022). Crossref, 2022. http://dx.doi.org/10.37539/221116.2022.22.27.007.
Full textLisikhina, N. V. "SOME ASPECTS OF SOCIOEPIDEMIOLOGICAL ANAMNESIS OF POISONING BY NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES WITH DEATH SOURCE." In Актуальные проблемы борьбы с преступностью: вопросы теории и практики. Сибирский юридический институт МВД России, 2017. http://dx.doi.org/10.51980/2017_1_68.
Full textWijenayake, Nirmani, Harvey R. Fernandez, Vibeke S. Catts, Noel J. Whitaker, and Louise H. Lutze-Mann. "Abstract 5549: Efficacy and potential mechanisms of psychotropic drugs and statins in the treatment of glioblastoma." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-5549.
Full textReports on the topic "Psychotropic drugs"
Woollard, Rachel. Positive Behavior Supports: An Alternative to the Overuse of Psychotropic Drugs. Portland State University Library, January 2014. http://dx.doi.org/10.15760/honors.70.
Full textSentcоv, Valentin, Andrei Reutov, and Vyacheslav Kuzmin. Electronic training manual "Acute poisoning with psychotropic substances". SIB-Expertise, January 2024. http://dx.doi.org/10.12731/er0777.29012024.
Full textRedkous, Vladimir Mikhailovich. Development of the Administrative and Legal Basis for the Turnover of Narcotic Drugs, Psychotropic Substances and Their Precursors in the Russian Federation and the CIS Member States. DOI СODE, 2022. http://dx.doi.org/10.18411/doicode-2023.090.
Full text